Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Thrombosis and Haemostasis|December 8, 2010
24-hour time-dependent aspirin efficacy in patients with stable coronary artery diseasePatrick Henry, Adeline Vermillet, Bernadette Boval, et al.Archives of Cardiovascular Diseases|July 30, 2019
Long-term outcome of heart transplantation performed after ventricular assist device compared with standard heart transplantationThibaut Petroni, Cosimo D'Alessandro, Alain Combes, et al.Archives of Cardiovascular Diseases|May 5, 2015
Sex-related differences after contemporary primary percutaneous coronary intervention for ST-segment elevation myocardial infarctionOlivier Barthélémy, Philippe Degrell, Emmanuel Berman, et al.Critical Care Medicine|May 10, 2014
Intra-aortic balloon pump effects on macrocirculation and microcirculation in cardiogenic shock patients supported by venoarterial extracorporeal membrane oxygenation*Thibaut Petroni, Anatole Harrois, Julien Amour, et al.Heart (British Cardiac Society)|July 15, 2016
Primary percutaneous coronary intervention for ST elevation myocardial infarction in nonagenariansThibaut Petroni, Azfar Zaman, Jean-Louis Georges, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 4, 2016
Low level exercise echocardiography helps diagnose early stage heart failure with preserved ejection fraction: a study of echocardiography versus catheterizationNadjib Hammoudi, Florent Laveau, Gérard Helft, et al.Journal of the American Heart Association|November 18, 2016
Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS TrialBarbara E Stähli, Catherine Gebhard, Valérie Duchatelle, et al.Journal of the American College of Cardiology|March 19, 2013
Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trialJean-Claude Tardif, Jean-François Tanguay, Scott R Wright, et al.Journal of the American Heart Association|July 18, 2024
PRADOC: A Multicenter Randomized Controlled Trial to Assess the Efficiency of PRADO-IC, a Nationwide Pragmatic Transition Care Management Plan for Hospitalized Patients With Heart Failure in FranceFrançois Roubille, Jean-Philippe Labarre, Frédéric Georger, et al.ESC Heart Failure|December 28, 2020
PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in FranceClaire Duflos, Jean-Philippe Labarre, Roxana Ologeanu, et al.Pageof 2